Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
|
|
| 7.77 Delayed Data As of Sep 23 |  -0.10 / -1.27%Today’s Change | 4.25 Today|||52-Week Range 11.21 | -10.79% Year-to-Date |
The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 15.00, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a +93.05% increase from the last price of 7.77.
The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since September, when it was unchanged from a rating.Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.
